Supported by clinical studies... enCurve reduces adipocytes counts rapidly, patients notice visible results & an average of 4-6 cm circumferential reduction can be achieved depending on individual condition after completing the program.
Selective fat targeting
enCurve's radio frequency of 27.12 MHz selectively targets & heats fat cells to trigger their apoptosis. This minimizes heat dissipation to surrounding tissues which increases the safety & comfort of the treatment.
enCurve requires no consumable like belts, tips, gels or cycle-fees as in competitor devices, hence it provides more pricing flexibility and increases the return of investment.
Almost no operator needed
Continuous operator presence is not needed due to enCurve's automatic energy monitoring function, this unique feature allows the clinic to run body shaping treatments without allocating or hiring more staff.
enCurve provides a relaxing patient experience by delivering the energy without touching the body. This is enabled by the large applicator that can cover the treated area from a distance.
Comfortable with no downtime
Due to the selectivity of enCurve energy, the patient feels only a slightly warm sensation in the treated area. Patients can go back directly to their daily activities with no downtime.